ABL Bio Inc is a biotechnology company based in South Korea that researches and develops antibody-based medicines. Its work centres on bispecific antibodies, which are engineered to bind two targets at once, and it has programmes in immuno-oncology and neuroscience. The company advances its drug candidates through preclinical and clinical testing, and it works with pharmaceutical partners on research collaborations and licensing arrangements. Its customers and collaborators are mainly drug developers and research organisations rather than patients directly.
ABL Bio Inc trades under the code 298380 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1674 of 1832 on the KOSDAQ · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Korea yet.
TrendWeak
3/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-62.8%
From 52-week high-81.0%
MomentumWeak
11/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-38.2%
6-month return-70.0%
12-month, skipping last month-39.3%
Stability (higher is calmer)Weak
13/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)91.3%
Worst drawdown, 1 year (smaller is calmer)-83.5%
LiquidityStrong
96/100
Trades actively.
See the numbers →
Avg daily value traded21,766.34M KRW
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Korea when fundamentals data for this market is added. All Korea stocks.
52-wk range 39,700.00 – 257,500.00Daily closes, split-adjusted
Signals
50-day average64,208.00
200-day average125,836.00
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)3,668.16
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
45,330.0
Bullish
EMA 10
46,163.2
Bullish
SMA 20
48,530.0
Bearish
EMA 20
49,759.1
Bearish
SMA 50
64,208.0
Bearish
EMA 50
61,167.1
Bearish
SMA 100
76,851.0
Bearish
EMA 100
78,999.9
Bearish
SMA 200
125,836.0
Bearish
EMA 200
97,840.4
Bearish
Oscillators (daily)
RSI (14)
39.59
Neutral
MACD (12, 26)
-5,365.6
Bearish
Momentum (12)
-12.78
Bearish
Stochastic %K (14)
47.00
Neutral
Williams %R (14)
-53.00
Neutral
CCI (20)
-40.38
Neutral
Pivot points (classic, last session)
S3
43,383.3
S2
44,316.7
S1
45,533.3
Pivot
46,466.7
R1
47,683.3
R2
48,616.7
R3
49,833.3
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in KRW. Educational only, not financial advice.
